微卫星稳定型结直肠癌的下一代精准肿瘤学:超越 RAS 和 RAF 的整合靶向治疗
Next-generation precision oncology in microsatellite stable colorectal cancer: integrated targeting beyond RAS and RAF.
MODALITY HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Next-generation precision oncology in microsatellite stable colorectal cancer: integrated targeting beyond RAS and RAF.
HER2-specific chimeric antigen receptor-T cells for targeted therapy of metastatic colorectal cancer.
Immunogenetic Metabolomics Reveals Key Enzymes That Modulate CAR T-cell Metabolism and Function.
Immunotherapy in GI Cancers: Lessons from Key Trials and Future Clinical Applications.
Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer.
Colorectal Cancer: Risk Factors, Novel Approaches in Molecular Screening and Treatment.
Immunogenetic metabolomics revealed key enzymes that modulate CAR-T metabolism and function.
MEMBER ACCOUNT
登录成功会直接打开下一页。